Showing 25 results
- Key Release /Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto (+…
- Media Release /Phase III V-MONO study met its primary endpoints, demonstrating superiority of Leqvio (inclisiran) monotherapy vs both placebo and ezetimibe in LDL-C reduction1 Results add to growing body of…
- Media Release /
Featured News /Novartis announced the company’s financial results for the first quarter of 2024.
Story /People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.